Regeneron Pharmaceuticals (REGN)

Trade REGN now with
2/6/2019 6:31:32 AM Regeneron Q4 GAAP EPS $7.15; Non-GAAP EPS $6.84
2/4/2019 1:00:37 AM Regeneron: CHMP Recommends Approval Of Praluent (alirocumab) Injection To Reduce Cardiovascular Risk
1/7/2019 2:33:49 AM Regeneron, Sanofi Restructure Immuno-Oncology Collaboration For Discovery And Development Programs
12/1/2018 12:33:54 PM Regeneron Presents Positive Data At ASH For REGN1979 CD20xCD3 Bispecific Antibody In R/R B-Cell Non-Hodgkin Lymphoma
11/12/2018 7:11:21 AM Ziopharm Announces Immuno-oncology Deal With Regeneron To Evaluate Combination Therapy For Patients With Brain Cancer
11/7/2018 5:08:11 PM Sanofi: NEJM Publish Positive Detailed Results Of The 18,924-patient ODYSSEY OUTCOMES Trial
11/6/2018 6:35:48 AM Regeneron Pharmaceuticals Q3 EPS $5.17 Vs $3.32 Last Year
10/25/2018 7:08:44 AM Regeneron Says Phase 3 PANORAMA Trial Of EYLEA Injection Meets Primary Endpoint And Key Secondary Endpoints
10/22/2018 7:02:47 AM Regeneron: FDA Approves Asthma Indication For Dupixent